Further analysis of Kaplan-Meier plotter-Ovarian cancer datasets showed that ovarian cancer patients with higher FAM46A expression had a shorter survival time and an earlier relapse survival time (P < 0.05; Figure 1(d)). Here, TENT5A is linked to ovarian carcinoma.